WO2005014021A3 - Utilisation d'un peptide zkw pour la preparation d'un medicament inhibiteur de l'agregation plaquettaire - Google Patents

Utilisation d'un peptide zkw pour la preparation d'un medicament inhibiteur de l'agregation plaquettaire

Info

Publication number
WO2005014021A3
WO2005014021A3 PCT/FR2004/002079 FR2004002079W WO2005014021A3 WO 2005014021 A3 WO2005014021 A3 WO 2005014021A3 FR 2004002079 W FR2004002079 W FR 2004002079W WO 2005014021 A3 WO2005014021 A3 WO 2005014021A3
Authority
WO
WIPO (PCT)
Prior art keywords
zkw
peptide
preparing
platelet aggregation
drug against
Prior art date
Application number
PCT/FR2004/002079
Other languages
English (en)
Other versions
WO2005014021A2 (fr
Inventor
Naziha Marrakchi
Kamel Mabrouk
Jean-Marc Sabatier
Ayeb Mohamed El
Herve Rochat
Original Assignee
Centre Nat Rech Scient
Univ Aix Marseille Ii
Pasteur Institut Tunis
Naziha Marrakchi
Kamel Mabrouk
Jean-Marc Sabatier
Ayeb Mohamed El
Herve Rochat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Aix Marseille Ii, Pasteur Institut Tunis, Naziha Marrakchi, Kamel Mabrouk, Jean-Marc Sabatier, Ayeb Mohamed El, Herve Rochat filed Critical Centre Nat Rech Scient
Publication of WO2005014021A2 publication Critical patent/WO2005014021A2/fr
Publication of WO2005014021A3 publication Critical patent/WO2005014021A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Utilisation d'un peptide ZKW et de certains peptides homologues, pour la préparation d'un médicament destiné à la prévention et/ou au traitement du phénomène d'agrégation plaquettaire.
PCT/FR2004/002079 2003-08-04 2004-08-03 Utilisation d'un peptide zkw pour la preparation d'un medicament inhibiteur de l'agregation plaquettaire WO2005014021A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309627 2003-08-04
FR0309627A FR2858557B1 (fr) 2003-08-04 2003-08-04 Utilisation d'un peptide zkw pour la preparation d'un medicament inhibiteur de l'agregation plaquettaire

Publications (2)

Publication Number Publication Date
WO2005014021A2 WO2005014021A2 (fr) 2005-02-17
WO2005014021A3 true WO2005014021A3 (fr) 2005-06-09

Family

ID=34073018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/002079 WO2005014021A2 (fr) 2003-08-04 2004-08-03 Utilisation d'un peptide zkw pour la preparation d'un medicament inhibiteur de l'agregation plaquettaire

Country Status (2)

Country Link
FR (1) FR2858557B1 (fr)
WO (1) WO2005014021A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117143194B (zh) * 2023-11-01 2024-02-06 北京大学第一医院 抗血小板聚集多肽、其制备方法及应用

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BLOOD, vol. 88, no. 12, 1996, pages 4579 - 4584 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1996, BOWDITCH ET AL.: "Characterization of autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries", XP002275802, Database accession no. PREV199799335786 *
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1973, STONER ET AL.: "Effects of bradykinin and indomethacin on cyclic GMP and cyclic AMP in lung slices", XP002275801, Database accession no. EMB-1974196023 *
HUANG ET AL.: "Characterization of three endogeneous peptide inhibitors for multiple metalloproteinases with fibrinogenolytic activity from the venom of Taiwan Habu (Trimeresurus mucrosquamatus)", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COOMUNICATIONS, vol. 248, no. 3, 30 June 1998 (1998-06-30), pages 562 - 568, XP002275800 *
PROCEEDINGS OF NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 70, no. 12 II, 1973, pages 3830 - 3833 *

Also Published As

Publication number Publication date
FR2858557B1 (fr) 2005-10-28
FR2858557A1 (fr) 2005-02-11
WO2005014021A2 (fr) 2005-02-17

Similar Documents

Publication Publication Date Title
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
AU2002240409A1 (en) Inhibition of platelet activation, aggregation and/or adhesion by hypothermia
WO2003074551A3 (fr) Conjugues d'agents therapeutiques ou cytotoxiques et de peptides bioactifs
EP1512396A4 (fr) Inhibiteurs de l'activation de ap-1 et de nfat
EP1650192A4 (fr) Derive de quinolone ou sel de ce dernier
WO2004091497A3 (fr) Methodes et compositions pouvant augmenter la capacite de travail anaerobie dans des tissus
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
IL184266A (en) Benzazole analogues, preparations containing them and their use as inhibitors of protein kinase
WO2002059143A3 (fr) Peptides therapeutiques pour troubles de la demyelinisation
WO2004062684A3 (fr) Inhibition de la signalisation pacap dans la prevention et le traitement de la thrombocytopenie
WO2002096348A3 (fr) Produit comprenant du mikanolide ou du dihydromikanolide en association avec un autre agent anti-cancereux
AU2003270149A1 (en) Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same
WO2007046842A3 (fr) Composition destinee a l'inhibition de cathepsine k
WO2004073615A3 (fr) Composes de deazaflavine et leurs methodes d'utilisation
IL197887A0 (en) New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
AU2003206367A1 (en) Technical field of the invention
WO2004080477A8 (fr) Aplidine utilisee dans le traitement du myelome multiple
WO2005014021A3 (fr) Utilisation d'un peptide zkw pour la preparation d'un medicament inhibiteur de l'agregation plaquettaire
AU2003288809A1 (en) Peptides that bind of the vegfr-2
WO2004003006A3 (fr) Peptides antimicrobiens pour la conservation des aliments
WO2004019965A3 (fr) Approches tolerogenes a base de thymus destinees au diabete de type i.
PT1532141E (pt) Derivados de 2-pirrolidin-2-il-[1,3,4]-oxadiazole e sua utilização como antidepressivos
GB2400642B (en) Valve permitting the injection of hydrate inhibitors
WO2007077454A3 (fr) Composition therapeutique
AU2003221096A1 (en) Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase